Screening guidelines — Europe and the United Kingdom

In short

Most countries in Europe and the United Kingdom run population-based colorectal cancer screening programmes built around the faecal immunochemical test (FIT), with coloscopy reserved for people whose FIT is positive or who have specific risk factors. The age range and the testing interval vary by country, but the broad pattern is similar: an at-home stool test mailed every two years to adults from their fifties through their seventies, with coloscopy as the diagnostic step that follows an abnormal result.

What this page covers

How national screening programmes work in the United Kingdom and across Europe, why the model differs from the United States, and what to expect if you are invited to screening or are choosing whether to participate. Country-by-country detail is given in directional terms — programme parameters change, and your invitation letter or national health service site is the authoritative source for your own situation.

The shared logic of European programmes
The four UK nations and how their programmes compare
A side-by-side view of selected European programmes
The role of coloscopy when FIT is positive
How to ask for screening if you have not been invited and think you should have been

The shared logic

European screening programmes are built on the European Council recommendation that member states offer organised, population-based colorectal cancer screening, and on the European guidelines for quality assurance in colorectal cancer screening produced under the European Commission's Initiative on Colorectal Cancer. The European Society of Gastrointestinal Endoscopy and the United European Gastroenterology federation publish related guidance on coloscopy quality.

The shared model has three features. First, screening is organised: invitations are mailed by a programme rather than triggered by a clinic visit. Second, the first-line test for average-risk adults is FIT (or, in some older programmes, the older guaiac-based stool test, now largely phased out). Third, coloscopy is the diagnostic test for those with a positive FIT and the screening test for those at higher risk because of family history, prior polyps, or known genetic syndromes.

This is a different shape from the United States, where coloscopy itself is offered as a first-line screening choice for average-risk adults and where screening is largely opportunistic — initiated at a clinic visit — rather than mailed out by a programme.

The United Kingdom

Each of the four UK nations operates its own bowel cancer screening programme. The general pattern is similar — an at-home FIT kit mailed every two years to adults across most of their fifties, sixties, and into the mid-seventies — but the precise age ranges differ between England, Scotland, Wales, and Northern Ireland, and have been changing over recent years as the lower age limit is extended.

The kit comes through the post with instructions: a small sample of stool is collected on a single occasion, sealed in the supplied tube, and posted back to a laboratory. The result arrives by letter within a few weeks. A normal result means a return to routine screening at the next interval. An abnormal result means an invitation to discuss coloscopy at a screening centre, which is performed by an accredited bowel cancer screening colonoscopist.

People older than the upper age of the programme can usually request a kit by phoning their national programme directly; ask your GP or the programme helpline. People with a family history that places them outside the average-risk pathway are referred to a separate surveillance route, often through a regional genetics service or a gastroenterology clinic.

The UK National Screening Committee oversees policy across the four nations. The British Society of Gastroenterology, working with the Association of Coloproctology of Great Britain and Ireland and Public Health England, has issued guidelines on post-polypectomy and post-cancer surveillance that determine what happens after polyps are found and removed. The National Institute for Health and Care Excellence (NICE) publishes related guidance on diagnostic pathways for suspected colorectal cancer in symptomatic patients.

Selected European programmes

The table below sketches the broad shape of several national programmes. Programme parameters change; treat this as a map rather than a timetable.

Country	First-line test	Typical age range	Interval
England, Scotland, Wales, Northern Ireland	FIT (mailed)	Lower age in fifties; upper age mid-seventies	Every two years
France	FIT (mailed)	Fifties through mid-seventies	Every two years
Netherlands	FIT (mailed)	Mid-fifties through mid-seventies	Every two years
Italy	FIT in most regions; sigmoidoscopy in some	Fifties through mid-seventies	Every two years (FIT) / once (sigmoidoscopy)
Spain	FIT (regionally administered)	Fifties through mid-seventies	Every two years
Germany	Choice of FIT or coloscopy	FIT from fifties; coloscopy from fifties (men) or mid-fifties (women)	FIT annually then biennial; coloscopy with a long interval and a repeat option
Poland, Czech Republic	Coloscopy and/or FIT	Fifties onward	Coloscopy with a long interval; FIT annually

Two patterns repeat across the table. First, FIT is the dominant screening tool in most European programmes, both because it is inexpensive and because it requires nothing of the patient beyond a stool sample at home. Second, in countries with a stronger endoscopy infrastructure — Germany, Poland, the Czech Republic — coloscopy is offered as a primary screening option alongside FIT.

What happens when FIT is positive

A positive FIT is not a diagnosis of cancer. It means there was enough human blood in the sample to warrant a closer look, and the great majority of positive results lead to coloscopy that finds either nothing, haemorrhoids (engorged veins in the lower rectum and anus), diverticulosis (small pouches in the wall of the colon), or polyps that are removed during the same procedure.

The coloscopy that follows a positive FIT in a national programme is performed by an accredited screening colonoscopist at a screening centre, with quality monitored by the programme. In the United Kingdom, screening coloscopy is performed by colonoscopists who meet specific training, audit, and outcome standards published by the Joint Advisory Group on GI Endoscopy. In other European countries, equivalent quality frameworks operate, often with reference to the European Society of Gastrointestinal Endoscopy's quality measures.

If polyps are found, they are usually removed during the same coloscopy and sent to pathology. The pathology report determines what happens next: most people return to programme screening, some are placed on a surveillance schedule with shorter intervals, and a small number are referred to a multidisciplinary cancer team if the findings warrant it.

If your symptoms do not fit a screening programme

Screening programmes are designed for adults who have no symptoms. If you have rectal bleeding, a clear change in bowel habit lasting weeks, unexplained weight loss, unexplained iron-deficiency anaemia, or a persistent change you cannot explain, the right pathway is not screening but a symptomatic referral. In the United Kingdom this is handled through your GP and may follow a suspected-cancer pathway with defined timeframes. In other European countries, equivalent rapid-access routes exist.

The distinction matters because screening tests, including FIT, are not designed to rule out cancer in someone who already has symptoms. A reassuring screening result in a person with new red-flag symptoms should not delay further investigation.

What to ask your clinician

Am I in the screening age range for my country, and what does my last invitation look like?
I have a family history that I am not sure about — does that move me out of the average-risk pathway?
I am older than the upper age limit of the programme — can I still request a kit?
If my FIT is positive, what is the local pathway to coloscopy and how long does it usually take?
Is the screening coloscopy done at a programme-accredited centre, and who will perform it?
If I have symptoms now, should I be on a symptomatic pathway rather than waiting for screening?
How do my routine medications, particularly blood thinners, affect the screening or follow-up plan?
If I move between European countries, how should I keep my screening continuous?

Common worries, briefly addressed

I never received a kit and I am the right age.

Invitations are tied to the address registered with your national health system. If you have moved, contacted the practice late, or recently registered, you may not yet be in the cycle. Phoning the programme helpline or your GP usually resolves this within a few weeks.

My FIT is positive — does that mean cancer?

No. A positive FIT is a finding of blood in the stool above a programme threshold. The most common findings on the follow-up coloscopy are no abnormality, haemorrhoids, or polyps that are removed. A minority lead to a diagnosis of cancer, and finding cancer at a screened stage is precisely the point of the programme.

I would rather have a coloscopy than do the home test.

In some European systems — Germany, the Czech Republic, Poland among them — coloscopy is offered as a primary screening option for average-risk adults. In the United Kingdom and most of Europe, coloscopy outside an abnormal FIT or a higher-risk pathway is generally not offered through the screening programme but may be available through private healthcare.

I am older than the upper age — am I still allowed to be screened?

In most UK and European programmes, yes — you can request a kit by contacting the programme directly. Whether continued screening is the right choice depends on your overall health, prior screening, and preferences. The page on older adults goes through the conversation.

Sources

European Council — recommendation on cancer screening
European Commission Initiative on Colorectal Cancer — European guidelines for quality assurance
European Society of Gastrointestinal Endoscopy — performance measures and screening guidelines
UK National Screening Committee — bowel cancer screening policy
NHS Bowel Cancer Screening Programme — public information for England, Scotland, Wales, and Northern Ireland
National Institute for Health and Care Excellence — guidance on suspected cancer pathways
British Society of Gastroenterology — surveillance and screening guidelines
Haute Autorité de Santé — French guidance on colorectal cancer screening